CGL
EDIT icon

Clarius Group LLC’s Editas Medicine EDIT Stock Holding History

Clarius Group LLC’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-87,231
Closed -$2.09M – 70
2017
Q3 		$2.09M Hold
87,231
– – 0.88% 20
2017
Q2 		$1.46M Hold
87,231
– – 0.6% 28
2017
Q1 		$1.95M Hold
87,231
– – 0.8% 22
2016
Q4 		$1.42M Hold
87,231
– – 0.6% 28
2016
Q3 		$1.18M Buy
+87,231
New +$1.79M 0.55% 30

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Clarius Group LLC's EDIT Position: Q4 2017 in Review

Clarius Group LLC sold out of Editas Medicine (EDIT) in Q4 2017, closing a stake of 87,231 shares — an estimated $2.09M sold.

Clarius Group LLC first reported a position in EDIT in Q3 2016 and held it in 5 quarters. The position peaked at $2.09M in Q3 2017. 151 funds tracked by Wall St. Rank hold EDIT as of Q4 2017.

  • Clarius Group LLC reported no remaining Editas Medicine position as of Q4 2017 after selling out during the quarter.
  • Clarius Group LLC sold 87,231 Editas Medicine shares in Q4 2017, an estimated $2.09M.
  • Clarius Group LLC first reported a position in Editas Medicine in Q3 2016 and held it in 5 quarters.
  • Clarius Group LLC's Editas Medicine position peaked at $2.09M in Q3 2017.
  • 151 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2017.

Based on Clarius Group LLC's 13F filing for Q4 2017, filed 9 Feb 2018.